Cargando…

Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin

BACKGROUND: Asialoglycoprotein receptor (ASGPR)-ligand-based separation combined with identification with Hep Par 1 or pan-cytokeratin (P-CK) antibody have been demonstrated to detect circulating tumor cells (CTCs) in hepatocellular carcinoma (HCC). The aim of this study was to develop an improved e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jun, Chen, Lei, Zhang, Xiaofeng, Zhang, Yu, Liu, Huiying, Sun, Bin, Zhao, Linlin, Ge, Naijian, Qian, Haihua, Yang, Yefa, Wu, Mengchao, Yin, Zhengfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999270/ https://www.ncbi.nlm.nih.gov/pubmed/24763545 http://dx.doi.org/10.1371/journal.pone.0096185

Ejemplares similares

pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2015)

Adaptation of the carbamoyl-phosphate synthetase enzyme in an extremophile fish
por: White, Lewis J., et al.
Publicado: (2020)

Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis
por: de Cima, Sergio, et al.
Publicado: (2015)

Neonatal-onset carbamoyl phosphate synthetase I deficiency: A case report
por: Yang, Xiaoyan, et al.
Publicado: (2017)

Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism
por: Wang, Yi, et al.
Publicado: (2017)

Molecular, biochemical, and clinical analyses of five patients with carbamoyl phosphate synthetase 1 deficiency
por: Fan, Lijuan, et al.
Publicado: (2019)

Novel Neonatal Variants of the Carbamoyl Phosphate Synthetase 1 Deficiency: Two Case Reports and Review of Literature
por: Yan, Beibei, et al.
Publicado: (2019)

Plasmodium sporozoite phospholipid scramblase interacts with mammalian carbamoyl-phosphate synthetase 1 to infect hepatocytes
por: Cha, Sung-Jae, et al.
Publicado: (2021)

Novel pathogenic variant (c.2947C > T) of the carbamoyl phosphate synthetase 1 gene in neonatal-onset deficiency
por: Bai, Ruimiao, et al.
Publicado: (2022)

The T1405N Carbamoyl Phosphate Synthetase Polymorphism Does Not Affect Plasma Arginine Concentrations in Preterm Infants
por: Moonen, Rob M. J., et al.
Publicado: (2010)

Carbamoyl Phosphate Synthetase Subunit MoCpa2 Affects Development and Pathogenicity by Modulating Arginine Biosynthesis in Magnaporthe oryzae
por: Liu, Xinyu, et al.
Publicado: (2016)

Ammonia-lowering activities and carbamoyl phosphate synthetase 1 (Cps1) induction mechanism of a natural flavonoid
por: Nohara, Kazunari, et al.
Publicado: (2015)

The Application of Neurodiagnostic Studies to Inform the Acute Management of a Newborn Presenting With Carbamoyl Phosphate Synthetase 1 Deficiency
por: McGowan, Meaghan, et al.
Publicado: (2021)

Increased Occurrence of Valproic Acid-Induced Hyperammonemia in Carriers of T1405N Polymorphism in Carbamoyl Phosphate Synthetase 1 Gene
por: Janicki, Piotr K., et al.
Publicado: (2013)

ERRATUM to “The Application of Neurodiagnostic Studies to Inform the Acute Management of a Newborn Presenting With Carbamoyl Phosphate Synthetase 1 Deficiency”
Publicado: (2021)

A Carbamoyl Phosphate Synthetase II (CPSII) Deletion Mutant of Toxoplasma gondii Induces Partial Protective Immunity in Mice
por: Zhuo, Xunhui, et al.
Publicado: (2021)

Anesthesia management in living-donor liver transplantation in a patient with carbamoyl phosphate synthetase deficiency: a case report
por: Matsushita, Hiroki, et al.
Publicado: (2022)

Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker
por: Ong, Khaa Hoo, et al.
Publicado: (2023)

Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer
por: Jiang, Zhen, et al.
Publicado: (2022)

Feasibility and Safety of Delayed Catheter Removal Technique in Percutaneous Trans-Hepatic Portal Vein Embolization
por: He, Chengjian, et al.
Publicado: (2022)

Association between the p.Thr1406Asn polymorphism of the carbamoyl-phosphate synthetase 1 gene and necrotizing enterocolitis: A prospective multicenter study
por: Moonen, Rob M., et al.
Publicado: (2016)

Novel Pathogenic Variant (c.580C>T) in the CPS1 Gene in a Newborn With Carbamoyl Phosphate Synthetase 1 Deficiency Identified by Whole Exome Sequencing
por: Choi, Rihwa, et al.
Publicado: (2017)

Carbamoyl phosphate and its substitutes for the uracil synthesis in origins of life scenarios
por: Ter-Ovanessian, Louis M. P., et al.
Publicado: (2021)

N‐carbamoylglutamate‐responsive carbamoyl phosphate synthetase 1 (CPS1) deficiency: A patient with a novel CPS1 mutation and an experimental study on the mutation's effects
por: Yap, Sufin, et al.
Publicado: (2019)

Relations between the intracellular pathways of the receptors for transferrin, asialoglycoprotein, and mannose 6-phosphate in human hepatoma cells
Publicado: (1989)

Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization
por: He, Chengjian, et al.
Publicado: (2022)

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
por: Pranatharthiharan, Sandhya, et al.
Publicado: (2017)

Asialoglycoprotein Receptor-Targeted Superparamagnetic Perfluorooctylbromide Nanoparticles
por: Li, Yang, et al.
Publicado: (2021)

In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor
por: Sun, Rensong, et al.
Publicado: (2021)

The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells
por: Trerè, D, et al.
Publicado: (1999)

Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma
por: Sun, Bin, et al.
Publicado: (2013)

Identifying squamous cell carcinoma and cytokeratin-derived amyloid with pan-cytokeratin AE1/AE3 during Mohs micrographic surgery
por: Sidey, Kirk, et al.
Publicado: (2020)

Endovascular treatment for delayed post-pancreaticoduodenectomy hemorrhage of unusual origin (splenic artery branch)
por: Wang, Xiangdong, et al.
Publicado: (2022)

Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE?
por: Ge, Naijian, et al.
Publicado: (2023)

Monensin inhibits intracellular dissociation of asialoglycoproteins from their receptor
Publicado: (1983)

Distribution of an asialoglycoprotein receptor on rat hepatocyte cell surface
Publicado: (1982)

Immunocytochemical localization of the receptor for asialoglycoprotein in rat liver cells
Publicado: (1982)

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
por: Ahn, Green, et al.
Publicado: (2021)

Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells
por: Sun, Bin, et al.
Publicado: (2017)

Verification of HE-based CTV in laryngeal and hypopharyngeal cancer using pan-cytokeratin
por: Ligtenberg, Hans, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5cp04hdm2lq271m8t0bc8pa8g3